[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369652-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369652-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pathological-significance-and-therapeutic-prospects-of-hccs-expression-patterns-in-lung-adenocarcinoma-research-article","Pathological significance and therapeutic prospects of HCCS expression patterns in lung adenocarcinoma - Research Article","","The study investigates Holocytochrome c synthase (HCCS) expression in lung adenocarcinoma (LUAD) and evaluates how expression patterns influence the tumor immune environment. Using multiple tumor databases, it maps HCCS associations across cancer types and focuses on links with M2-type macrophages that promote tumor progression. Elevated HCCS in LUAD corresponds with increased M2 macrophage abundance, while differences in HCCS levels relate to immune cell infiltration and variability in treatment responsiveness. The findings support HCCS as a driver of immune landscape remodeling and a potential therapeutic target in LUAD and similar cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pathological-significance-and-therapeutic-prospects-of-hccs-expression-patterns-in-lung-adenocarcinoma-research-article/369652/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pathological-significance-and-therapeutic-prospects-of-hccs-expression-patterns-in-lung-adenocarcinoma-research-article/369652.png","ImageObject",300,407,{"name":42,"@type":43},"Chumphorn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is HCCS and why is it investigated in lung adenocarcinoma?","Question",{"text":63,"@type":64},"HCCS is a key component of the eukaryotic cytochrome c biosynthesis pathway. The study examines its expression, prognostic value, and potential functional impact in LUAD, where its role is described as still ambiguous.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does HCCS expression relate to the tumor immune environment in LUAD?",{"text":68,"@type":64},"High HCCS expression in LUAD is associated with increased M2-type macrophages. Variations in HCCS levels also influence immune cell infiltration and the tumor immune context that affects therapy responsiveness.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are M2-type macrophages important for tumor progression and treatment response?",{"text":72,"@type":64},"M2 macrophages are described as supporting tumor growth, facilitating immune evasion, and influencing how tumors respond to treatment. The study connects HCCS with these immunosuppressive macrophage phenotypes to explain therapeutic implications.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369652,1790506312,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","CELL ADHESION & MIGRATION  \n2025, VOL. 19, NO. 1, 2520632 [https://doi.org/10.1080/19336918.2025.2520632](https://doi.org/10.1080/19336918.2025.2520632)  \nRESEARCH ARTICLE     \nPathological significance and therapeutic prospects of HCCS expression patterns in lung adenocarcinoma  \nPengfei Luoa\\#, Sixuan Wub\\#, Zhimin Lib\\#, Shuangfeng Tanb, Lijun Zengb, Yuanbing Tangb, Lunqi Luob, Yuehua Lib, and Zhaohui Tanga  \naDepartment of Oncology, The Central Hospital of Yongzhou, Yongzhou, Hunan, China; bDepartment of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China  \nABSTRACT  \nThis study examines Holocytochrome c synthase (HCCS) expression in lung adenocarcinoma (LUAD) and its impact on the tumor immune environment. By analyzing multiple tumor databases, the research highlights HCCS expression patterns across various cancer types, focusing on its correlation with M2-type macrophages, which aid tumor progression. Findings show that high HCCS expressionin LUAD is associated with increased M2-type macrophages, and variations in HCCS levels influence immune cell infiltration and cancer therapy responsiveness. It suggests that HCCS significantly shapes the immune landscape within tumors, promoting growth and spread, and underscores its potential as a therapeutic target in LUAD and other cancers with similar expression profiles.  \nGraphical abstract on the crucial role of HCCS in modulating the tumor microenvironment (TME) and drug sensitivity with potential as a therapeutic target. This graphical abstract summarizes the central findings of the study, illustrating the crucial role of HCCS in modulating the tumor microenvironment and influencing drug sensitivity. The figure highlights how HCCS affects immune cell infiltration, macrophage polarization, and cancer cell response to therapy, emphasizing its potential as a therapeutic target in lung adenocarcinoma and possibly other cancers. Overview of HCCS’s role in TME modulation and drug sensitivity, highlighting its potential as a therapeutic target.  \nARTICLE HISTORY  \nReceived 14 August 2024 Revised 17 December 2024 Accepted 11 June 2025  \nKEYWORDS  \nDrug sensitivity;  \nholocytochrome C synthase; lung adenocarcinoma; macrophage polarization; therapeutic targets; tumor microenvironment  \nCONTACT Yuehua Li  [liyuehua2020@stu.usc.edu.cn](liyuehua2020@stu.usc.edu.cn)  Department of Oncology, the First Affiliated Hospital, Hengyang Medical School, University of South China, 69 Chuanshan Road, Hengyang, Hunan 421001, China; Zhaohui Tang  [tzhui2022@126.com](tzhui2022@126.com)  Department of Oncology, The Central Hospital of Yongzhou, No. 396 Yiyun Road, Yongzhou, Hunan 425000, China  \n\\#These authors are regarded as co-first authors.  \nThis article has been corrected with minor changes. These changes do not impact the academic content of the article.  Supplemental data for this article can be accessed online at [https://doi.org/10.1080/19336918.2025.2520632](https://doi.org/10.1080/19336918.2025.2520632)[ ](https://doi.org/10.1080/19336918.2025.2520632)© 2025 The Author(s) . Published by Informa UK Limited, trading as Taylor & Francis Group.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.  \nIntroduction  \nDespite considerable advancements in cancer treatment technologies in recent years, the survival rate for lung adenocarcinoma (LUAD) remains distressingly low [ 1– 6] . Notably, immune therapies, including immune checkpoint inhibitors (ICIs), have been sanctioned as primary a","cbCainRHJ1zjrJh5","https://ap.wps.com/l/cbCainRHJ1zjrJh5","pdf",18948472,21,"English","# Introduction\n## Lung adenocarcinoma treatment challenge and need for biomarkers\n## Role of tumor microenvironment and immune therapy responsiveness\n## HCCS in cytochrome c biosynthesis and cancer relevance\n## Macrophage polarization and link to therapeutic targeting\n# Study rationale and objectives (expression, prognosis, CNA, and TME correlation)","[{\"question\":\"What is HCCS and why is it investigated in lung adenocarcinoma?\",\"answer\":\"HCCS is a key component of the eukaryotic cytochrome c biosynthesis pathway. The study examines its expression, prognostic value, and potential functional impact in LUAD, where its role is described as still ambiguous.\"},{\"question\":\"How does HCCS expression relate to the tumor immune environment in LUAD?\",\"answer\":\"High HCCS expression in LUAD is associated with increased M2-type macrophages. Variations in HCCS levels also influence immune cell infiltration and the tumor immune context that affects therapy responsiveness.\"},{\"question\":\"Why are M2-type macrophages important for tumor progression and treatment response?\",\"answer\":\"M2 macrophages are described as supporting tumor growth, facilitating immune evasion, and influencing how tumors respond to treatment. The study connects HCCS with these immunosuppressive macrophage phenotypes to explain therapeutic implications.\"}]","Pathological significance and therapeutic prospects of HCCS expression patterns in lung adenocarcinoma - Research Article | PDF",1790183910,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fb9b1ca0c33b7acc209ba58e49bcfd3.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e28aef7a8a2893feddf8a94406966067.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9efd797437fb93eaa7ca646018ae2dda.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/563291316f9aa69d1686470597c43acd.webp",980,1306]